Data as of Jul 22
| +0.018 / +3.09%|
The 1 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +66.67% increase from the last price of 0.60.
The current consensus among 1 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.